These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32299298)

  • 1. Sample size calculation and re-estimation based on the prevalence in a single-arm confirmatory diagnostic accuracy study.
    Stark M; Zapf A
    Stat Methods Med Res; 2020 Oct; 29(10):2958-2971. PubMed ID: 32299298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blinded sample size re-estimation in a comparative diagnostic accuracy study.
    Stark M; Hesse M; Brannath W; Zapf A
    BMC Med Res Methodol; 2022 Apr; 22(1):115. PubMed ID: 35439947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size determination and re-estimation for matched pair designs with multiple binary endpoints.
    Xu J; Yu M
    Biom J; 2013 May; 55(3):430-43. PubMed ID: 23553605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of the two-sample t-test statistic following blinded sample size re-estimation.
    Lu K
    Pharm Stat; 2016 May; 15(3):208-15. PubMed ID: 26865383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size re-estimation in paired comparative diagnostic accuracy studies with a binary response.
    McCray GPJ; Titman AC; Ghaneh P; Lancaster GA
    BMC Med Res Methodol; 2017 Jul; 17(1):102. PubMed ID: 28705147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size recalculation based on the prevalence in a randomized test-treatment study.
    Hot A; Benda N; Bossuyt PM; Gerke O; Vach W; Zapf A
    BMC Med Res Methodol; 2022 Jul; 22(1):205. PubMed ID: 35879675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blinded sample size re-estimation for recurrent event data with time trends.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Dec; 32(30):5448-57. PubMed ID: 24105855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends.
    Asendorf T; Henderson R; Schmidli H; Friede T
    Stat Med; 2019 Apr; 38(9):1503-1528. PubMed ID: 30575061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinded sample size recalculation in clinical trials with binary composite endpoints.
    Sander A; Rauch G; Kieser M
    J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-calculating the sample size in internal pilot study designs with control of the type I error rate.
    Kieser M; Friede T
    Stat Med; 2000 Apr; 19(7):901-11. PubMed ID: 10750058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size re-estimation in a breast cancer trial.
    Hade EM; Jarjoura D; Lai Wei
    Clin Trials; 2010 Jun; 7(3):219-26. PubMed ID: 20392786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive power.
    Liu Q; Hu G; Ye B; Wang S; Wu Y
    Pharm Stat; 2023 Mar; 22(2):349-364. PubMed ID: 36418025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized test-treatment studies with an outlook on adaptive designs.
    Hot A; Bossuyt PM; Gerke O; Wahl S; Vach W; Zapf A
    BMC Med Res Methodol; 2021 Jun; 21(1):110. PubMed ID: 34074263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size re-estimation in adaptive enrichment design.
    Lin R; Yang Z; Yuan Y; Yin G
    Contemp Clin Trials; 2021 Jan; 100():106216. PubMed ID: 33246098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size re-estimation in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Stat Methods Med Res; 2019 Jun; 28(6):1852-1878. PubMed ID: 29869564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.